FADDA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 402
AS - Asia 77
EU - Europa 77
Totale 556
Nazione #
US - Stati Uniti d'America 399
CN - Cina 48
UA - Ucraina 25
SG - Singapore 16
DE - Germania 15
IT - Italia 14
TR - Turchia 13
GB - Regno Unito 9
FI - Finlandia 5
SE - Svezia 5
CA - Canada 3
CZ - Repubblica Ceca 3
FR - Francia 1
Totale 556
Città #
Fairfield 62
Woodbridge 49
Ann Arbor 36
Houston 33
Jacksonville 28
Seattle 27
Chandler 22
Cambridge 20
Wilmington 18
Santa Clara 15
Ashburn 14
Beijing 13
Singapore 12
Milan 7
Kunming 6
Shanghai 6
Boardman 5
Izmir 5
Princeton 5
San Mateo 5
Ferrara 4
San Diego 4
Brno 3
Jiaxing 3
Ningbo 3
Tappahannock 3
Auburn Hills 2
Hebei 2
Jinan 2
Los Angeles 2
Mountain View 2
Munich 2
Nanchang 2
Nanjing 2
New York 2
Norwalk 2
Ottawa 2
Philadelphia 2
Redmond 2
Shenyang 2
Bari 1
Bremen 1
Changsha 1
Dearborn 1
Falls Church 1
Frankfurt am Main 1
Indiana 1
Leawood 1
Redwood City 1
San Francisco 1
Toronto 1
Zhengzhou 1
Totale 448
Nome #
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 120
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 110
null 89
null 86
null 83
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 37
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 20
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 18
Totale 563
Categoria #
all - tutte 2.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.548


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 0 0 15 11 14 13 16 12 5
2020/202174 7 7 1 8 7 5 1 9 2 9 12 6
2021/202247 2 4 6 0 1 5 3 3 3 5 2 13
2022/202354 3 3 0 6 11 6 5 6 8 0 3 3
2023/202424 3 3 0 0 1 2 1 2 2 0 0 10
2024/202542 1 9 9 4 19 0 0 0 0 0 0 0
Totale 563